Thirumalai Chemicals Ltd
Thirumalai Chemicals Q3 FY26 investor presentation: Revenue & Margins
Q3 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Thirumalai Chemicals Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentationreports, not management guidance.
The short version
Q3 FY26 Revenue from Operations (INR Cr): - Standalone: 300 vs 498 in Q3 FY25 (YoY decline of 39%) - Consolidated: 416 vs 447 in Q3 FY25 (YoY decline of 6%) - Total Income (INR Cr): - Standalone: 307 vs 504 in Q3 FY25 (YoY decline of 39%) - Consolidated: 420 vs 447 in Q3 FY25 (YoY decline of 6%) - Outlook: - Page 23 notes subdued paints demand due to prolonged monsoon, expected to stabilize in Q4. Q3 FY26 Financials (Consolidated): - EBITDA: -11 Cr (vs.
From Thirumalai Chemicals Ltd's Q3 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Q3 FY26 Revenue from Operations (INR Cr):
- Standalone: 300 vs 498 in Q3 FY25 (YoY decline of 39%)
- Consolidated: 416 vs 447 in Q3 FY25 (YoY decline of 6%)
- Total Income (INR Cr):
- Standalone: 307 vs 504 in Q3 FY25 (YoY decline of 39%)
- Consolidated: 420 vs 447 in Q3 FY25 (YoY decline of 6%)
- Outlook:
- Page 23 notes subdued paints demand due to prolonged monsoon, expected to stabilize in Q4.
- PAn demand volume-driven but cautious buying with aggressive price negotiations in Q3.
- Global chemical demand remains weak with utilization 70–75%.
2 more points from Thirumalai Chemicals Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Thirumalai Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Building a 40 KTPA Maleic Anhydride (MAn) capacity facility in the USA (New Martinsville, West Virginia)
- The USA facility will also produce Malic Acid and Fumaric Acid (food ingredients)
- Plant advantages: located near gas fields and ports, feedstock availability within 70 miles, proximity to 40% of the US MAn market within 1,000 miles
- The new USA plant is fully integrated, allowing self-generated energy use and expansion of food ingredient portfolio (Malic Acid and Fumaric Acid)
- Ongoing capex for MAn & food ingredients totaling 40.5 KTPA capacity at the USA operation
2 more points from Thirumalai Chemicals Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Fundraising & Capital Structure
See what Thirumalai Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Thirumalai Chemicals Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Thirumalai Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹416 Cr, net loss ₹47 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Thirumalai Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio Solutions Ltd (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Jubilant Agri & Consumer Products Ltd (Q3 FY26)
Q3 FY26 Revenue from Operations: INR 4,510 million, up 13% YoY from INR 3,975 million in Q3 FY25 (Page 20). Key investor presentation takeaways from Jubilant Ag
- Chemfab Alka. (Q3 FY26)
Revenue from Operation: ₹62.17 crore, down 21.51% YoY (₹79.21 crore in Q3FY25) . Key investor presentation takeaways from Chemfab Alka.'s Q3 FY26 investor prese
- Galaxy Surfactants Ltd (Q3 FY26)
. Key concall takeaways from Galaxy Surfactants Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
Arthneeti Pro · Annual
Thirumalai Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Thirumalai Chemicals Ltd Q3 FY26 results?
Q3 FY26 Revenue from Operations (INR Cr): - Standalone: 300 vs 498 in Q3 FY25 (YoY decline of 39%) - Consolidated: 416 vs 447 in Q3 FY25 (YoY decline of 6%) - Total Income (INR Cr): - Standalone: 307 vs 504 in Q3 FY25 (YoY decline of 39%) - Consolidated: 420 vs 447 in Q3 FY25 (YoY decline of 6%) - Outlook: - Page 23 notes subdued paints demand due to prolonged monsoon, expected to stabilize in Q4. Q3 FY26 Financials (Consolidated): - EBITDA: -11 Cr (vs.
What is Thirumalai Chemicals Ltd share price analysis?
Thirumalai Chemicals Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,716 Cr. Investors should review the full earnings analysis for detailed insights.
Is Thirumalai Chemicals Ltd planning capital expenditure?
Building a 40 KTPA Maleic Anhydride (MAn) capacity facility in the USA (New Martinsville, West Virginia) - The USA facility will also produce Malic Acid and Fumaric Acid (food ingredients) - Plant
Keep Thirumalai Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.